OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: David Kent

1 Projects | 1 Researchers | $599,788 Invested

2023

TUFTS Medical Center

David Kent, MD, MS

Covert Cerebrovascular Disease Detected by Artificial Intelligence (C2D2AI): Pilot Investigation for Pragmatic Neuroimaging Biomarkers for Future Stroke and Dementia Risk

  • Funding Amount: $599,788
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Vascular
  • Status: Active